疟疾疫苗研发进展综述
本综述探讨疟疾疫苗研发的最新进展与未来方向,强调需新方法实现针对疟原虫的可持续保护。研究覆盖红前期、血液期和传播阻断等多阶段候选疫苗,RTS,S/AS01与R21/Matrix-M已在非洲通过国家扩大免疫规划实施。实现疟疾消除仍需改进现有疫苗策略、整合新技术并强化流行区交付机制。
要点
- 疟疾疫苗研发覆盖红前期、血液期和传播阻断等多阶段策略。
- RTS,S/AS01与R21/Matrix-M已在非洲通过国家扩大免疫规划推广。
- 红前期抗原鉴定受限于感染性子孢子获取和可靠人肝细胞模型建立。
核心结论
- 实现全球疟疾消除仍具挑战性,需改进现有疫苗策略、整合新技术并强化流行区交付机制以克服生物学和操作障碍。
研究设计与样本
- 本文为综述,探讨疟疾疫苗研发的最新进展与未来方向,未报告系统检索范围。
主要发现
- 早期研究强调免疫原性抗原和佐剂对增强免疫应答的重要性,推动多阶段疫苗研发。
- 近期多项候选疫苗处于不同试验阶段,包括红前期、血液期和传播阻断疫苗,研究合作趋势增强。
- 红前期抗原鉴定因感染性子孢子获取困难及可靠人肝细胞模型建立困难而持续面临挑战。
- 质谱、生物信息学和结构生物学的进展有望填补上述空白。
- 非洲疟疾负担最重,RTS,S/AS01和R21/Matrix-M疫苗正通过国家扩大免疫规划实施,需社区参与和卫生系统准备。
关键数值与推荐
- RTS,S/AS01和R21/Matrix-M疫苗已在非洲通过国家扩大免疫规划接种程序实施。
临床怎么用
- 在非洲等高负担地区,应通过国家扩大免疫规划推进RTS,S/AS01和R21/Matrix-M疫苗接种,并加强社区参与和卫生系统准备。
- 需关注下一代疫苗的持久性和广度,以弥补当前疫苗策略的不足。
局限性
- 红前期抗原鉴定受限于感染性子孢子获取困难和人肝细胞模型建立困难。
- 实现疟疾消除仍面临生物学和操作层面的双重障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite progress in reducing the burden of malaria, achieving global malaria elimination remains challenging. This review explores recent advances and future directions in malaria vaccine development, highlighting the need for new approaches to achieve sustainable protection against Plasmodium species. Early research emphasized the importance of immunogenic antigens and adjuvants to strengthen immune responses, prompting efforts to develop vaccines targeting multiple stages of the parasite's life cycle. Recent initiatives have showcased diverse vaccine candidates in various trial phases, including pre-erythrocytic, blood stage, and transmission blocking vaccines, reflecting an encouraging shift toward more collaborative research. However key challenges persist, particularly in identifying pre-erythrocytic antigens owing to difficulties in obtaining infectious sporozoites and establishing reliable human hepatocyte models. Nevertheless, advances in mass spectrometry, bioinformatics, and structural biology hold promise in filling these gaps. In Africa, where the burden of malaria is the highest, the implementation of the RTS,S/AS01 and R21/Matrix-M vaccines through national Expanded Program on Immunization schedules is under way, underscoring the importance of community engagement and health system readiness while highlighting the need for next generation vaccines with greater durability and breadth. Achieving elimination of malaria requires improving current vaccine strategies, integrating novel technologies, and strengthening delivery mechanisms in endemic regions to overcome both biological and operational barriers.
引用
- Sorgho H, Rouamba T, Natama HM, et al. Advances in the development of malaria vaccines. BMJ. 2026. PMID: 42297417. doi:10.1136/bmj-2025-084166
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。